Cargando…
The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147751/ https://www.ncbi.nlm.nih.gov/pubmed/34046207 http://dx.doi.org/10.2144/fsoa-2021-0035 |
_version_ | 1783697695952601088 |
---|---|
author | Franzese, Elisena Falco, Stefano De Laterza, Maria Maddalena Montella, Liliana Facchini, Sergio Liguori, Carmela Coppola, Paola Diessa, Ylenia Berretta, Massimiliano Pisconti, Salvatore Trama, Francesco Ferro, Matteo Crocetto, Felice Fasano, Morena Buonerba, Carlo Facchini, Gaetano |
author_facet | Franzese, Elisena Falco, Stefano De Laterza, Maria Maddalena Montella, Liliana Facchini, Sergio Liguori, Carmela Coppola, Paola Diessa, Ylenia Berretta, Massimiliano Pisconti, Salvatore Trama, Francesco Ferro, Matteo Crocetto, Felice Fasano, Morena Buonerba, Carlo Facchini, Gaetano |
author_sort | Franzese, Elisena |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8147751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Future Science Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-81477512021-05-26 The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities Franzese, Elisena Falco, Stefano De Laterza, Maria Maddalena Montella, Liliana Facchini, Sergio Liguori, Carmela Coppola, Paola Diessa, Ylenia Berretta, Massimiliano Pisconti, Salvatore Trama, Francesco Ferro, Matteo Crocetto, Felice Fasano, Morena Buonerba, Carlo Facchini, Gaetano Future Sci OA Editorial Future Science Ltd 2021-04-07 /pmc/articles/PMC8147751/ /pubmed/34046207 http://dx.doi.org/10.2144/fsoa-2021-0035 Text en © 2021 Carlo Buonerba https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Editorial Franzese, Elisena Falco, Stefano De Laterza, Maria Maddalena Montella, Liliana Facchini, Sergio Liguori, Carmela Coppola, Paola Diessa, Ylenia Berretta, Massimiliano Pisconti, Salvatore Trama, Francesco Ferro, Matteo Crocetto, Felice Fasano, Morena Buonerba, Carlo Facchini, Gaetano The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities |
title | The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities |
title_full | The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities |
title_fullStr | The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities |
title_full_unstemmed | The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities |
title_short | The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities |
title_sort | use of (68)ga prostate-specific membrane antigen pet-ct in prostate cancer: diagnostic challenges and therapeutic opportunities |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147751/ https://www.ncbi.nlm.nih.gov/pubmed/34046207 http://dx.doi.org/10.2144/fsoa-2021-0035 |
work_keys_str_mv | AT franzeseelisena theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT falcostefanode theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT laterzamariamaddalena theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT montellaliliana theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT facchinisergio theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT liguoricarmela theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT coppolapaola theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT diessaylenia theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT berrettamassimiliano theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT piscontisalvatore theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT tramafrancesco theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT ferromatteo theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT crocettofelice theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT fasanomorena theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT buonerbacarlo theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT facchinigaetano theuseof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT franzeseelisena useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT falcostefanode useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT laterzamariamaddalena useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT montellaliliana useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT facchinisergio useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT liguoricarmela useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT coppolapaola useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT diessaylenia useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT berrettamassimiliano useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT piscontisalvatore useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT tramafrancesco useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT ferromatteo useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT crocettofelice useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT fasanomorena useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT buonerbacarlo useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities AT facchinigaetano useof68gaprostatespecificmembraneantigenpetctinprostatecancerdiagnosticchallengesandtherapeuticopportunities |